These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


56 related items for PubMed ID: 6144134

  • 1. Incidence of tardive dyskinesia: five-year data from a prospective study.
    Kane JM, Woerner M, Weinhold P, Wegner J, Kinon B.
    Psychopharmacol Bull; 1984; 20(1):39-40. PubMed ID: 6144134
    [No Abstract] [Full Text] [Related]

  • 2. Five-year prospective study of clinical EEG, neuropsychological, and demographic risk variables for persistent tardive dyskinesia.
    Struve FA.
    Adv Biochem Psychopharmacol; 1985; 40():33-6. PubMed ID: 2862766
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Do atypical antipsychotic agents cause tardive dyskinesia?
    Bailey KP.
    J Psychosoc Nurs Ment Health Serv; 2004 Oct; 42(10):14-9. PubMed ID: 15540874
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tardive dyskinesia and glucid metabolism.
    Brousse G, Meary A, Mouret J, Blanc O, Hueber T, Lemoine P, Llorca PM, Lachaux B.
    Hum Psychopharmacol; 2007 Aug; 22(6):373-80. PubMed ID: 17579925
    [Abstract] [Full Text] [Related]

  • 15. Epidemiology of tardive dyskinesia in the elderly.
    Blowers AJ.
    Neuropharmacology; 1981 Dec; 20(12B):1339-40. PubMed ID: 6119647
    [No Abstract] [Full Text] [Related]

  • 16. Tardive dyskinesia in mentally retarded children, adolescents, and young adults: North Carolina and Michigan studies.
    Gualtieri CT, Breuning SE, Schroeder SR, Quade D.
    Psychopharmacol Bull; 1982 Jan; 18(1):62-5. PubMed ID: 6152872
    [No Abstract] [Full Text] [Related]

  • 17. Substance abuse as a risk factor for tardive dyskinesia: a retrospective analysis of 1,027 patients.
    Bailey LG, Maxwell S, Brandabur MM.
    Psychopharmacol Bull; 1997 Jan; 33(1):177-81. PubMed ID: 9133772
    [Abstract] [Full Text] [Related]

  • 18. Tardive dyskinesia: epidemiologic factors as a guide for prevention and management.
    Casey DE.
    Adv Biochem Psychopharmacol; 1985 Jan; 40():15-24. PubMed ID: 2862762
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Worsening of psychosis in schizophrenia is longitudinally associated with tardive dyskinesia in the European Schizophrenia Outpatient Health Outcomes study.
    Tenback DE, van Harten PN, Slooff CJ, van Os J, SOHO Study Group.
    Compr Psychiatry; 2007 Jan; 48(5):436-40. PubMed ID: 17707251
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.